Janssen Pharmaceutica has announced results from two Phase III clinical studies of esketamine nasal spray, a drug closely related to ketamine, in patients with treatment-resistant depression. Janssen Pharmaceutica has reported results from two Stage III clinical investigations of esketamine nasal shower, a medication firmly connected with ketamine, in patients with treatment-safe sadness....